论文部分内容阅读
本文对36例肾、胆、输尿管上段结石病人行ESWL治疗前、中、末进行无创性血液循环功能检测。结果表明:碎石治疗中、末期,心室后负荷的诸指标明显升高,但心功能正常,无动脉硬化者,左心收缩力及血管顺应性诸指标同步增加而得以代偿;若病人心功能储备力不足,血管顺应性差(如有明显动脉硬化、冠心病等等),难以代偿碎石治疗中后负荷的增加而可能诱发心衰以至心跳骤停。故认为,对有器质性心脏病者行ESWL治疗应从严掌握,对有心脏扩大、心功能减退及有心衰史者应列为相对禁忌证。
In this paper, 36 cases of renal, gallbladder, ureteral calculi in patients with ESWL before, during, and non-invasive blood circulation function test. The results showed that: the gravel treatment, the end of the post-ventricular post-load indicators were significantly increased, but normal heart function, no atherosclerosis, left ventricular contractility and vascular compliance indicators increased simultaneously to be compensated; if the patient’s heart Insufficient functional reserve, poor vascular compliance (if significant atherosclerosis, coronary heart disease, etc.), it is difficult to compensate for the increase in mid-and-late load of gravel therapy and may lead to heart failure and cardiac arrest. Therefore, those who have organic heart disease ESWL treatment should be strictly controlled, have a heart enlargement, cardiac dysfunction and heart failure should be listed as a relative contraindication.